Rosetta Genomics (ROSG)

Add to Watchlists
Create an Alert
3.82 -0.06  -1.57% NASDAQ May 22, 5:01PM Delayed 2m USD
View Full Chart
ROSG Price Chart
View All Events

ROSG Events

Date Type Description
03/17/2015 10:00 EDT Misc Rosetta Genomics Ltd Fourth Quarter Earnings Conference Call in 2014
03/16/2015 Earnings Rosetta Genomics Ltd Fourth Quarter Earnings in 2014 Release
09/18/2014 10:00 EDT Misc Rosetta Genomics Ltd Q2 2014 Earnings Conference Call
09/18/2014 Earnings Rosetta Genomics Ltd Q2 2014 Earnings Results
View All Performance Charts

ROSG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Rosetta Genomics is up 0.79% over the last year vs S&P 500 Total Return up 14.93%, Sarepta Therapeutics down 16.09%, and Wafergen Bio-systems down 67.77%.

Advertisement

ROSG Profile

Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.

ROSG Excel Add-In Codes

  • Name: =YCI("ROSG","name")
  • Description: =YCI("ROSG","description")
  • Sector: =YCI("ROSG","sector")
  • Industry: =YCI("ROSG","industry")
  • Est. Current Fiscal Year End: =YCI("ROSG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.